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Asymmetric dimethylarginine (ADMA) and its enantiomer, symmetric dimethylarginine 
(SDMA), are naturally occurring amino acids that are generated intracellularly from 
L-arginine. ADMA is an endogenous competitive inhibitor of nitric oxide synthase. 
Increased levels of ADMA and SDMA are associated with endothelial dysfunction, 
hypertension, cardiovascular and renal diseases. Both compounds are accumulating in 
chronic kidney disease (CKD) patients. The aim of this diploma thesis was to develop 
and validate a liquid chromatography with tandem mass spectrometry (LC-MS/MS) 
method for the determination of L-arginine, ADMA and SDMA in human plasma. 
Subsequently, LC-MS/MS method was compared with enzyme-linked immunosorbent 
assay (ELISA) and high-performance liquid chromatography with fluorescence detection 
(HPLC-FL) method. Chromatographic separation was performed on Dionex UltiMate 
3000 UHPLC liquid chromatograph, followed by tandem mass spectrometric detection 
on amaZon SL mass spectrometer. L-Arginine-13C6, ADMA-d6 and SDMA-d6 were used 
as the internal standards. Sample preparation included precolumn derivatization by 
1-butanol. Multiple reaction monitoring (MRM) in positive mode was used for analyte 
quantification. Developed LC-MS/MS method showed very good analytical properties 
meeting the conditions for its validation and it is comparable with the previously 
published methods of other authors. Plasma levels of ADMA and SDMA obtained by the 
LC-MS/MS method correlated very well with those obtained by ELISA and HPLC-FL 
method. Plasma levels of ADMA and SDMA were measured in plasma samples obtained 
from healthy volunteers (n = 40) and patients CKD (n = 40). Both ADMA and SDMA 
levels were significantly elevated in the patients with CKD.  
